×
Volver a Agenda
LS31: New System of Clinical Notification for Complexed Clinical Trials
Session Chair(s)
Toshinori Higashi, PhD
Vice President, Regulatory Science
KAKEN PHARMACEUTICAL CO.,LTD., Japan
Speaker(s)
Daisuke Sato
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Coordinator, Office of Review Management
Noriko Morikubo
Pfizer R&D Japan G.K., Japan
Regulatory Strategy Group2, Japan Regulatory Portfolio Lead
Hitomi Okuma, MD, PhD
National Cancer Center Hospital, Japan
Head, International Research and Development Section
¿Tiene una cuenta?